BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2002
View Archived Issues
A crossover study provides evidence of the analgesic properties of reboxetine
Read More
NC-1900 improves place learning deficits in rats after transient forebrain ischemia
Read More
Fumagillin is effective against intestinal microsporidiosis in immunocompromised patients
Read More
New PDE4 inhibitors in early development at Merck KGaA
Read More
New ERbeta modulators and their use in Alzheimer's, anxiety, osteoporosis, etc.
Read More
Novel MCH antagonists covered by Schering-Plough patent
Read More
Ishihara Sangyo describes new inhibitors of Th1 and/or Th2 cytokine production
Read More
New ACAT inhibitors prepared and tested by Pola researchers
Read More
Alkermes and Reliant call off merger
Read More
Ovation acquires Tranxene and Desoxyn from Abbott
Read More
Aphton seeks E.U. clearance for G17DT trial in GERD
Read More
Yamanouchi discontinues YM-175
Read More
MT-100 provides significant pain relief in difficult-to-treat migraine patients
Read More
Antisoma completes enrollment in phase I TheraFab trial
Read More
Xcytrin to enter new phase III trial in NSCLC patients
Read More
Ortho Tri-Cyclen Lo receives FDA approval
Read More
